Biological activities of [Thr2]sarafotoxin-b, a synthetic analogue of sarafotoxin-b.
The 21 amino acid sarafotoxins (SRTX) c and d/e as well as endothelin-3 (ET-3) are known to be less toxic and weaker pharmacologically than the other isopeptides SRTX-a, SRTX-b and ET-1. Since SRTX-c, SRTX-d/e and ET-3 possess a Thr instead of a Ser at position 2, we investigated the possibility that this mutation could be responsible for the observed biological differences. Here we show that the synthetic [Thr2]SRTX-b has indeed a lower vasoconstriction efficacy (approximately 35%) in the rabbit aorta, but it is nearly as potent as SRTX-b in toxicity tests and in influencing contraction of the rat uterus. Using monoclonal antibodies directed against the structurally related endothelin-1, we also show that the antigenicity of the analogue is comparable to that of SRTX-b, suggesting that the overall structure of the two peptides is similar, despite the substitution at position 2. We suggest that the Thr2 substitution contributes to the lower activity of the 'weak' peptides in some systems; however, additional substitutions found in the 'weak' peptides of the ET/SRTX family most probably contribute to their low pharmacological activity.
Lamthanh
H
H
Departement d'Ingenierie, Etudes des Proteines, DSV, CEA, CE, Gif sur Yvette, France.
Bdolah
A
A
Creminon
C
C
Grassi
J
J
Menez
A
A
Wollberg
Z
Z
Kochva
E
E
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001011:Aorta / Q000187:drug effects; D001667:Binding, Competitive; D002851:Chromatography, High Pressure Liquid; D004562:Electrocardiography / Q000187:drug effects; D016232:Endothelins / Q000737:chemistry / Q000276:immunology / Q000633:toxicity; D005260:Female; D007124:Immunoenzyme Techniques; D007928:Lethal Dose 50; D051379:Mice; D008969:Molecular Sequence Data; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014590:Uterine Contraction / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000737:chemistry / Q000633:toxicity*; D014757:Viper Venoms / Q000737:chemistry / Q000145:classification / Q000633:toxicity*
D000911:Antibodies, Monoclonal; D016232:Endothelins; D014662:Vasoconstrictor Agents; D014757:Viper Venoms; C057354:sarafotoxins s6